Consistently, P2X1-null AML cells had much lower levels of glycolysis and oxidative phosphorylation as evidenced by the notable reduction in ATP, ECARs, and OCRs than WT counterparts (Fig. S4H–J). This evidence concerns the gene P2RX1 and acute myeloid leukemia.